Updated on 9 June 2016
Six organizations representing life sciences and health clusters in Europe and Australia have signed a business development agreement today at BIO International Convention 2016 in San Francisco. The agreement is expected to help fast-track business results for companies and solve a common problem for small-to-medium enterprises (SMEs) - landing in new markets.
The organizations are from five regions: Adelaide (Australia), Catalonia (Spain), Auvergne-Rhone Alpes Region (France), Bavaria (Germany) and Piedmont (Italy).
The two Australian organizations, BioSA and Health Industries South Australia, signed the agreement on behalf of over 100 health industries companies and research organizations in Adelaide, a city with a fast-growing health and life sciences sector.
"Everyone has been working very hard to deliver this agreement and I'm glad it has been finalized here at BIO 2016," said Health Industries South Australia CEO, Marco Baccanti. "This cooperative effort will deliver real, practical results for companies and research organisations across all our regions, and is particularly exciting for Adelaide as it focuses on growing its health industries."
Over A$3 billion is being invested in health and life sciences infrastructure at Adelaide BioMed City - one of the largest health and life sciences clusters in the southern hemisphere, bringing together research, education, clinical care, and business incubation and development.
"This agreement will benefit South Australian companies targeting European markets enabling them to create networks for potential commercialization partners and customers," said Dr Meera Verma, Acting CEO of BioSA. "It will facilitate exports, research collaboration and commercial outcomes and provide opportunities for job creation within the high-tech health sector in South Australia."